Fingerprint
Dive into the research topics of 'Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer
Joan H. Schiller, Joachim Von Pawel, Philipp Schütt, Rafat H. Ansari, Michael Thomas, Mansoor Saleh, Robert D. McCroskey, Wolfgang Pfeifer, Thomas A. Marsland, Goetz H. Kloecker, Martin Sebastian, Robert Pirker, Raffael Kurek, Claire Beadman, Mark A. Socinski
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations